RACHAEL PETERSON: Open Payments
NPI 1891417788 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 70 payments from 28 companies in 2025. Trend: 2023 $505 · 2024 $1,604 · 2025 $1,756
Food & beverage: $1,586Education: $170
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $313 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $213 |
| Janssen Biotech, Inc. | 4 | $173 |
| Medtronic, Inc. | 3 | $165 |
| Astellas Pharma US Inc | 4 | $95 |
| UROGEN PHARMA, INC. | 3 | $87 |
| SEAGEN INC. | 1 | $85 |
| TOLMAR, INC. | 3 | $79 |
| PFIZER INC. | 6 | $71 |
| Ferring Pharmaceuticals Inc. | 1 | $52 |
Products named: GEMTESA, ERLEADA, ORGOVYX, Xtandi, INTERSTIM, Nubeqa, Xofigo, ELIGARD.
Industry payments across GA — which companies pay providers there.
